Myles Greenberg

Myles Greenberg

Algemeen Directeur bij
InCarda Therapeutics, Inc.
58 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Myles D.
Greenberg
is currently Chief Executive Officer at InCarda Therapeutics, Inc. since 2024.
He is a Director at Urgent Care Centers of New England, Inc. He is a Partner at CHL Healthcare Partners LLC since 2013 and a Venture Partner at Healthinvest Equity Partners.
Formerly, Dr. Greenberg was President, Chief Executive Officer & Director at Alucent Biomedical Inc. from 2017 to 2024.
He served as Chairman at Cantex Pharmaceuticals, Inc. and held Director positions at Oriel Therapeutics, Inc., Angiomics, Inc., Millennium Pharmacy Systems, Inc., NuVasive LLC, Dynogen Pharmaceuticals, Inc., Vertos Medical, Inc., Ivrea Pharmaceuticals, Inc., Oculir, Inc., DICOM Grid, Inc., FlowCardia, Inc., and Mevion Medical Systems, Inc. as an Independent Director.
He was Assistant Clinical Director-Emergency Department at Beth Israel Deaconess Medical Center, Inc. and Assistant Clinical Director-Emergency Medicine at Harvard Medical School.
He was Senior Principal at Pappas Capital LLC from 2000 to 2003 and Assistant Professor at UNC School of Medicine.
Education includes an MBA from Harvard Business School in 2000, a doctorate from Yale School of Medicine in 1993, and an undergraduate degree from the School of Engineering & Applied Science in 1989.

Actieve functies van Myles Greenberg

BedrijvenFunctieBegin
Private Equity Investor 01-01-2004
Directeur/Bestuurslid -
Private Equity Investor -
Algemeen Directeur 10-12-2024

Eerdere bekende functies van Myles Greenberg

BedrijvenFunctieEinde
Algemeen Directeur 02-11-2024
Directeur/Bestuurslid 23-10-2008
Corporate Officer/Principal 31-12-2003
Directeur/Bestuurslid -
NUVASIVE, INC. Directeur/Bestuurslid -
Ervaring van Myles Greenberg in detail bekijken

Opleiding van Myles Greenberg

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

98

Eerstegraads connecties

24

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit24

Health Technology

Angiomics, Inc.

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Finance

Health Services

Health Technology

Consumer Services

Commercial Services

Health Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Finance

Commercial Services

  1. Beurs
  2. Insiders
  3. Myles Greenberg